tyrosine methyl ester and Leishmaniasis
tyrosine methyl ester has been researched along with Leishmaniasis in 1 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arora, SK; Garg, P; Jain, SK; Kaur, A; Kumar, R; Sharma, SS; Singh, IP; Singh, S | 1 |
Other Studies
1 other study(ies) available for tyrosine methyl ester and Leishmaniasis
Article | Year |
---|---|
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
Topics: Alkaloids; Amino Acids; Animals; Antiprotozoal Agents; Benzodioxoles; Catalytic Domain; Cricetinae; Esters; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Male; Models, Molecular; Piperidines; Polyunsaturated Alkamides | 2010 |